TERAPIA INCRETINOMIMTICA: RESTAURANDO LA FUNCIN INCRETINA La necesidad de desarrollar nuevos frmacos antidiabticos con menos efectos adversos que los hipoglucemiantes orales comunes, como la sulfonilureas o tiazolidinedionas que incrementan el riesgo de hipoglicemia, aumento de peso o mortalidad cardiovascular, dio lugar a dos enfoques basados en el efecto incretina: los inhibidores de la DPP-4 (IDPP-4) y los agonistas del receptor del GLP-1 (GLP1-RA)
Can GLP-1 analogues be used during pregnancy or breastfeeding
For most medications, this delay is clinically insignificant
For others, especially those with more significant nutrient imbalances, the benefits may become more noticeable after a few consistent injections
Companies such as Givaudan, Kerry, and FrieslandCampina Ingredients have all highlighted their solutions to support this transition, ranging from complex aromas to probiotics that support digestive health in GLP-1 users [3] [4] [7]